Finley John David's Form 4 filing
Palisade Bio, Inc. (PALI) · filed Feb 13, 2026
- Accession no.
- 0001493152-26-006831
- Filed
- Feb 13, 2026
- Trade date
- Feb 11-12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.82K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Finley John DavidCIK 0001851034 | Director, Officer (CEO, CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Common Stock | MOption exerciseAcquired | +13,333 | –F1 | – | 31,249 | Direct | |
| Feb 12, 2026 | Common Stock | SSaleDisposed | −3,896 | $1.75 | −$6,818 | 27,353 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Common Stock | MOption exerciseDisposed | −13,333 | $0.00 | $0 | 26,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 11, 2025.
Referenced by the price of 1 transaction in Table I.